Detalles de la búsqueda
1.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
N Engl J Med
; 388(18): 1645-1656, 2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133584
2.
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.
Breast Cancer Res Treat
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38837087
3.
Diabetes is associated with high risk of severe adverse events during chemotherapy for cancer patients: A single-center study.
Int J Cancer
; 152(3): 408-416, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054752
4.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161271
5.
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Ann Surg
; 277(1): e153-e161, 2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33534229
6.
Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients.
Int J Cancer
; 150(11): 1850-1860, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038360
7.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207609
8.
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 191(1): 191-207, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687411
9.
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.
Reprod Biomed Online
; 44(6): 1031-1044, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525718
10.
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
Int J Cancer
; 145(12): 3359-3369, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087564
11.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Breast Cancer Res Treat
; 173(2): 397-406, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357526
12.
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 26(2): 356-365, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30539492
13.
Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy.
Reprod Biomed Online
; 36(6): 711-718, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523398
14.
Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Reprod Biomed Online
; 36(5): 543-551, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29506861
15.
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Breast Cancer Res Treat
; 165(2): 329-341, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612225
16.
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Br J Clin Pharmacol
; 83(3): 623-631, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662818
17.
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 16(15): 1556-1568, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482278
18.
CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
J Neurooncol
; 117(1): 117-24, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24469852
19.
[Should we take into account the informational stress of the medical oncologist?] / Doit-on prendre en compte le stress informationnel de l'oncologue médical ?
Bull Cancer
; 111(2): 222-227, 2024 Feb.
Artículo
en Francés
| MEDLINE | ID: mdl-38199834
20.
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
Eur J Cancer
; 196: 113422, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977105